Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

Journal of Experimental Medicine

Volumn 204, Issue 12, 2007, Pages 3027-3036

  Alter, Galit ^a   Martin, Maureen P ^b   Teigen, Nickolas ^a   Carr, William H ^a   Suscovich, Todd J ^a   Schneidewind, Arne ^a   Streeck, Hendrik ^a   Waring, Michael ^a   Meier, Angela ^a   Brander, Christian ^a   Lifson, Jeffrey D ^b   Allen, Todd M ^a   Carrington, Mary ^b   Altfeld, Marcus ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; KIR3DS1; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CYTOLYSIS; DISEASE COURSE; GENE LOCUS; GENE TARGETING; HLA TYPING; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIREMIA; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; KINETICS; RECEPTORS, KIR; VIRUS REPLICATION;

EID: 36549019907     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070695     Document Type: Article

References (49)

1. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
2. Martin, M.P., M. Dean, M.W. Smith, C. Winkler, B. Gerrard, N.L. Michael, B. Lee, R.W. Doms, J. Margolick, S. Buchbinder, et al. 1998. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science. 282:1907-1911.
3. Smith, M.W., M. Dean, M. Carrington, C. Winkler, G.A. Huttley, D.A. Lomb, J.J. Goedert, T.R. O ' Brien, L.P. Jacobson, R. Kaslow, et al. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science. 277:959-965.
4. Carrington, M., and S.J. O ' Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
5. Gao, X., G.W. Nelson, P. Karacki, M.P. Martin, J. Phair, R. Kaslow, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, et al. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344:1668-1675.
6. Kaslow, R.A., M. Carrington, R. Apple, L. Park, A. Munoz, A.J. Saah, J.J. Goedert, C. Winkler, S.J. O ' Brien, C. Rinaldo, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
7. Martin, M.P., X. Gao, J.H. Lee, G.W. Nelson, R. Detels, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434.
8. Cooper, M.A., T.A. Fehniger, and M.A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
9. Bukowski, J.F., and R.M. Welsh. 1986. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 136:3481-3485.
10. Reading, P.C., P.G. Whitney, D.P. Barr, M.J. Smyth, and A.G. Brooks. 2006. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur. J. Immunol. 36:897-905.
11. Daniels, K.A., G. Devora, W.C. Lai, C.L. O ' Donnell, M. Bennett, and R.M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194:29-44.
12. Biron, C.A., G. Sonnenfeld, and R.M. Welsh. 1984. Interferon induces natural killer cell blastogenesis in vivo. J. Leukoc. Biol. 35:31-37.
13. Biron, C.A., K.S. Byron, and J.L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
14. Khakoo, S.I., C.L. Thio, M.P. Martin, C.R. Brooks, X. Gao, J. Astemborski, J. Cheng, J.J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 305:872-874.
15. Carrington, M., S. Wang, M.P. Martin, X. Gao, M. Schiffman, J. Cheng, R. Herrero, A.C. Rodriguez, R. Kurman, R. Mortel, et al. 2005. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J. Exp. Med. 201:1069-1075.
16. Chen, C., M. Busson, V. Rocha, M.L. Appert, V. Lepage, N. Dulphy, P. Haas, G. Socie, A. Toubert, D. Charron, and P. Loiseau. 2006. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant. 38:437-444.
17. Bashirova, A.A., M.P. Martin, D.W. McVicar, and M. Carrington. 2006. The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense (*). Annu. Rev. Genomics Hum. Genet. 7 : 277-300.
18. Carrington, M., and P. Norman. 2003. The KIR Gene Cluster. NCBI, Bethesda, MD. 48 pp.
19. Carr, W.H., D.B. Rosen, H. Arase, D.F. Nixon, J. Michaelsson, and L.L. Lanier. 2007. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178:647-651.
20. Trundley, A., H. Frebel, D. Jones, C. Chang, and J. Trowsdale. 2007. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 37:780-787.
21. Carr, W.H., M.J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175:5222-5229.
22. Thananchai, H., G. Gillespie, M.P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D.W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178:33-37.
23. Gumperz, J.E., L.D. Barber, N.M. Valiante, L. Percival, J.H. Phillips, L.L. Lanier, and P. Parham. 1997. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J. Immunol. 158:5237-5241.
24. Cella, M., A. Longo, G.B. Ferrara, J.L. Strominger, and M. Colonna. 1994. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180:1235-1242.
25. Welsh, R.M., C.A. Biron, J.F. Bukowski, K.W. McIntyre, and H. Yang. 1984. Role of natural killer cells in virus infections of mice. Surv. Synth. Pathol. Res. 3:409-431.
26. Moretta, A., C. Bottino, M.C. Mingari, R. Biassoni, and L. Moretta. 2002. What is a natural killer cell? Nat. Immunol. 3:6-8.
27. Vitale, M., S. Sivori, D. Pende, R. Augugliaro, C. Di Donato, A. Amoroso, M. Malnati, C. Bottino, L. Moretta, and A. Moretta. 1996. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sci. USA. 93:1453-1457.
28. Zambello, R., M. Falco, M. Della Chiesa, L. Trentin, D. Carollo, R. Castriconi, G. Cannas, S. Carlomagno, A. Cabrelle, T. Lamy, et al. 2003. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood. 102:1797-1805.
29. O'Connor, G.M., K.J. Guinan, R.T. Cunningham, D. Middleton, P. Parham, and C.M. Gardiner. 2007. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 178:235-241.
30. Alter, G., J.M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods. 294:15-22.
31. Martin, M.P., Y. Qi, X. Gao, E. Yamada, J.N. Martin, F. Pereyra, S. Colombo, E.E. Brown, W.L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740.
32. Jennes, W., S. Verheyden, C. Demanet, C.A. Adje-Toure, B. Vuylsteke, J.N. Nkengasong, and L. Kestens. 2006. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J. Immunol. 177:6588-6592.
33. Vieillard, V., J.L. Strominger, and P. Debre. 2005. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. USA. 102:10981-10986.
34. Ward, J., M. Bonaparte, J. Sacks, J. Guterman, M. Fogli, D. Mavilio, and E. Barker. 2007. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood. 110:1207-1214.
35. Stewart-Jones, G.B., K. di Gleria, S. Kollnberger, A.J. McMichael, E.Y. Jones, and P. Bowness. 2005. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLAB*2705. Eur. J. Immunol. 35:341-351.
36. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645-650.
37. Stewart, C.A., F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, F.A. Arosa, et al. 2005. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA. 102:13224-13229.
38. Malnati, M.S., M. Peruzzi, K.C. Parker, W.E. Biddison, E. Ciccone, A. Moretta, and E.O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science. 267:1016-1018.
39. Peruzzi, M., K.C. Parker, E.O. Long, and M.S. Malnati. 1996. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 157:3350-3356.
40. Peruzzi, M., N. Wagtmann, and E.O. Long. 1996. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184:1585-1590.
41. Altfeld, M., and P. Goulder. 2007. " Unleashed " natural killers hinder HIV. Nat. Genet. 39:708-710.
42. Kim, S., J. Poursine-Laurent, S.M. Truscott, L. Lybarger, Y.J. Song, L. Yang, A.R. French, J.B. Sunwoo, S. Lemieux, T.H. Hansen, and W.M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 436:709-713.
43. Anfossi, N., P. Andre, S. Guia, C.S. Falk, S. Roetynck, C.A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 25:331-342.
44. Mavilio, D., G. Lombardo, A. Kinter, M. Fogli, A. La Sala, S. Ortolano, A. Farschi, D. Follman, R. Gregg, C. Kovacs, et al. 2006. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J. Exp. Med. 203:2339-2350.
45. Lodoen, M.B., and L.L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18:391-398.
46. Alter, G., N. Teigen, R. Ahern, H. Streeck, A. Meier, E.S. Rosenberg, and M. Altfeld. 2007. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J. Infect. Dis. 195:1452-1460.
47. Schmitz, J.E., M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, M.A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B.J. Scallon, et al. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283:857-860.
48. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998.
49. Yang, O.O., and B.D. Walker. 1997. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273-311.